Intelligence · Clinical pipeline
Metabolic & obesity · Phase I
Metabolic & obesity programs at Phase I — ClinicalTrials.gov pipeline intelligence.
Programs 148
Quick answer
Metabolic & obesity Phase I programs: NovaPharmaNews indexes 148 matching clinical development programs from ClinicalTrials.gov with sponsor, modality, and NCT cross-links.
Top sponsors
- NovoThirteen 27 programs
- Sunshine Guojian Pharmaceutical 10 programs
- Anaxis Pharma 9 programs
- ENANTA PHARMACEUTICALS 7 programs
- First People's Hospital 6 programs
- Regeneron UK 6 programs
- United Therapeutics Europe 6 programs
- Eli Lilly and 5 programs
- Boehringer Ingelheim 4 programs
- HOFFMANN-LA ROCHE 4 programs
- BRIGHT MINDS BIOSCIENCES 3 programs
- Chinese Academy of 3 programs
Pipeline programs
-
pyroglutamate rongliflozin capsules
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Type 2 Diabetes
1 trial -
pyroglutamate rongliflozin capsules
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Diabetes Mellitus, Type 2
1 trial -
removal of omentum
United Therapeutics Europe Ltd
Diabetes Mellitus Type 2
1 trial -
salvianolic acid A
The First People's Hospital of Lianyungang
Diabetes
1 trial
Frequently asked questions
How many metabolic & obesity Phase I programs exist?
148 programs match both the therapeutic area and stage filters in our published index.